D05 - Optimizing Diabetes Technology Education and Support for Individuals with Disabilities

Sunday, August 10, 2025

10:00 AM – 10:45 AM MT

CE/CME Hours: .75 CE

Primary Presenter(s)

JB

Julia Blanchette, PhD, RN, BC-ADM, CDCES

Nurse Scientist, Assistant Professor
University Hospitals, Case Western
Cleveland, Ohio

Disclosure(s): Eli Lilly: Consultant / Advisory Board (Ongoing); Embecta: Consultant / Advisory Board (Ongoing); Insulet Corporation: Speakers' Bureau (Ongoing)

Co-Presenter(s)

AH

Allyson Hughes, PhD

Assistant Professor
Ohio University Heritage College of Osteopathic Medicine
Athens, Ohio

Disclosure(s): No financial relationships to disclose

This session provides a comprehensive overview of diabetes technology considerations when supporting people with disabilities. We will discuss disparities and barriers to diabetes self-management for people who are blind, low vision, deaf, hard of hearing, or have intellectual or developmental disabilities, such as down syndrome, and autism spectrum disorder. We will present strategies for managing diabetes and enhancing technology such as continuous glucose monitors, automated insulin delivery systems, and smart pens in these populations. Case studies will illustrate real-world applications of accessibility strategies and successful diabetes technology usage. The session will conclude with resources for individuals with disabilities and diabetes and the DCES team members.

Disclosure(s):

Julia Blanchette, PhD, RN, BC-ADM, CDCES: Eli Lilly: Consultant / Advisory Board (Ongoing); Embecta: Consultant / Advisory Board (Ongoing); Insulet Corporation: Speakers' Bureau (Ongoing)

Allyson Hughes, PhD: No financial relationships to disclose